SHANK3 and Behcet disease: Although some of the behavioral abnormalities of Shank3 TG mice could also be observed in mice modeling other disorders such as ASDs and SCZ, the Shank3 TG mice responded to valproic acid, a Food and Drug Administration (FDA)-approved drug for the treatment of manic or mixed episodes in BD (Han et al., 2013b).